Edarbi Prices, Coupons, Copay Cards & Patient Assistance
Edarbi (azilsartan medoxomil) is a member of the angiotensin receptor blockers drug class and is commonly used for High Blood Pressure.
Edarbi is available as a brand name drug only, a generic version is not yet available. View generic Edarbi availability for more details.
Edarbi prices
Oral Tablet
40 mg Edarbi oral tablet from $260.98 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $8.70 | $260.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
80 mg Edarbi oral tablet from $282.98 for 30 tablets
| Quantity | Per unit | Price |
|---|---|---|
| 30 | $9.43 | $282.98 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Edarbi Coupons, Copay Cards and Rebates
Edarbi offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Edarbi Copay Savings Card
Eligible commercially insured patients may pay as little as $15 per prescription.
- Applies to:
- Edarbi
- Number of uses:
- Per prescription until program expires
Form more information phone: 877-264-2440
Edarbi Azurity Solutions E-Z RX
Eligible commercially insured patients pay $15 per 30-day prescription at participating pharmacies.
- Applies to:
- Edarbi
- Number of uses:
- Per prescription until program expires
Patient Assistance & Copay Programs for Edarbi
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Edarbi (azilsartan medoxomil) Tablet
More information please phone: 866-316-7263 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
More about Edarbi (azilsartan medoxomil)
- Check interactions
- Compare alternatives
- Reviews (45)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: angiotensin receptor blockers
- Breastfeeding
- En español